Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization.

Détails

ID Serval
serval:BIB_D98A05D25553
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization.
Périodique
Epilepsia
Auteur(s)
Spatola M., Alvarez V., Rossetti A.O.
ISSN
1528-1167 (Electronic)
ISSN-L
0013-9580
Statut éditorial
Publié
Date de publication
2013
Volume
54
Numéro
8
Pages
e99-e102
Langue
anglais
Notes
Publication types: Journal Article; PDF : brief communication
Résumé
Benzodiazepine (BDZ), a widely recognized first-line status epilepticus (SE) treatment, may lead to respiratory depression. This cohort study investigates the effect of BDZ doses in SE patients in terms of morbidity and mortality. It considers incident SE episodes from a prospective registry (2009-2012), comparing patients receiving standard BDZ dose to those receiving exceeding doses (>30% above recommended dose), in terms of likelihood to receive intubation, morbidity, and mortality. Duration of hospitalization was assessed for subjects needing intubation for airways protection (not for refractory SE treatment) versus matched subjects not admitted to the intensive care unit (ICU). We identified 29 subjects receiving "excessive" and 173 "standard" BDZ dose; 45% of the overtreated patients were intubated for airways protection, but only 8% in the standard-dose group (p < 0.001). However, both groups presented similar clinical outcomes: 50% returned to baseline, 40% acquired a new handicap, and 10% died. Orotracheal intubation due to airways protection was associated with significantly longer hospitalization (mean 2 weeks vs. 1 week, p = 0.008). In conclusion, although administration of excessive BDZ doses in SE treatment does not seem to influence outcome, it is related to higher respiratory depression risk and longer hospitalization, potentially exposing patients to additional complications and costs.
Pubmed
Web of science
Open Access
Oui
Création de la notice
08/09/2013 10:19
Dernière modification de la notice
09/05/2019 2:01
Données d'usage